Holen Sie sich die Stockscreener-App
0.35
1.41%
-0.005
Vorhandelsmarkt:
.35
Schlusskurs vom Vortag:
$0.355
Offen:
$0.3546
24-Stunden-Volumen:
2.88M
Relative Volume:
0.40
Marktkapitalisierung:
$40.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-27.11M
KGV:
-0.5385
EPS:
-0.65
Netto-Cashflow:
$-26.55M
1W Leistung:
+1.10%
1M Leistung:
-47.39%
6M Leistung:
-18.47%
1J Leistung:
-77.85%
1-Tages-Spanne:
$0.3333
$0.3559
1-Wochen-Bereich:
$0.321
$0.39
52-Wochen-Spanne:
$0.25
$2.15
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Company Profile
Firmenname
Reviva Pharmaceuticals Holdings Inc
Sektor
Branche
Telefon
(408) 501-8881
Adresse
10080 N WOLFE ROAD, CUPERTINO
Vergleichen Sie RVPH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
RVPH
Reviva Pharmaceuticals Holdings Inc
|
0.35 | 41.48M | 0 | -27.11M | -26.55M | -0.65 |
|
VRTX
Vertex Pharmaceuticals Inc
|
449.53 | 115.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
754.14 | 79.76B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
799.33 | 50.16B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
366.86 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.75 | 38.85B | 4.98B | 69.59M | 525.67M | 0.5197 |
Reviva Pharmaceuticals Holdings Inc Stock (RVPH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-29 | Eingeleitet | Chardan Capital Markets | Buy |
| 2023-09-20 | Eingeleitet | ROTH MKM | Buy |
| 2023-06-08 | Eingeleitet | The Benchmark Company | Speculative Buy |
| 2022-01-24 | Eingeleitet | H.C. Wainwright | Buy |
Reviva Pharmaceuticals Holdings Inc Aktie (RVPH) Neueste Nachrichten
Sentiment Watch: How sensitive is Reviva Pharmaceuticals Holdings Inc Equity Warrant to inflationEarnings Growth Report & Stepwise Trade Signal Guides - baoquankhu1.vn
Sectors Review: Will Reviva Pharmaceuticals Holdings Inc benefit from green energy policiesJuly 2025 Spike Watch & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Aug Levels: Is Reviva Pharmaceuticals Holdings Inc Equity Warrant stock a top pick in earnings season2025 Fundamental Recap & Low Drawdown Momentum Ideas - Bộ Nội Vụ
Breakouts Watch: How Reviva Pharmaceuticals Holdings Inc stock reacts to Fed rate cutsWeekly Stock Analysis & Community Consensus Trade Alerts - Bộ Nội Vụ
Profit Recap: Can Reviva Pharmaceuticals Holdings Inc Equity Warrant withstand a market correctionAnalyst Downgrade & Verified Chart Pattern Trade Signals - baoquankhu1.vn
Reviva Pharmaceuticals Holdings (RVPH) Records 37% in 2026 So far - Finviz
Reviva Pharmaceuticals Holdings (RVPH) Records 37% Gain So far in 2026 - Yahoo Finance
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock deliver sustainable ROEQuarterly Earnings Summary & Fast Entry Momentum Trade Alerts - Улправда
Is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock a top pick in earnings seasonJuly 2025 Weekly Recap & High Conviction Trade Alerts - Улправда
Aug Opening: How strong is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock revenue growth2025 Fundamental Recap & Long-Term Investment Growth Plans - Улправда
symbol__ Stock Quote Price and Forecast - CNN
How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock benefits from tech adoptionRate Cut & Entry and Exit Point Strategies - Улправда
Is Reviva Pharmaceuticals Holdings Inc. stock trading near support levels2025 Market Outlook & High Yield Equity Trading Tips - Улправда
How strong is Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock revenue growth2025 Fundamental Recap & Long-Term Investment Growth Plans - Улправда
Will Tonix Pharmaceuticals Holding Corp. stock see insider buyingTrade Volume Report & Smart Allocation Stock Tips - Улправда
Reviva Pharmaceuticals Holdings, Inc. Announces Publication on Clinical Vocal Biomarker Data from the Recover Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia - marketscreener.com
Aug PreEarnings: How Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock benefits from tech adoption2025 Macro Impact & Weekly Chart Analysis and Trade Guides - Улправда
Will Reviva Pharmaceuticals Holdings Inc. stock maintain dividend yield2025 Retail Activity & Daily Profit Maximizing Trade Tips - Улправда
Reviva Announces Publication on Clinical Vocal Biomarker Data from the RECOVER Phase 3 Clinical Trial of Brilaroxazine to Treat Negative Symptoms in Schizophrenia - The Manila Times
Reviva Announces Publication on Clinical Vocal Biomarker - GlobeNewswire
Will Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock continue dividend increases - Улправда
Can Reviva Pharmaceuticals Holdings Inc. Equity Warrant stock continue upward trendBlue Chip Stock Analysis & Free Long-Term Investment Planning - Улправда
Worth Investment Trading Company Limited Shows Risk Reward Favoring Upside - Early Times
Chardan Capital assumes coverage on Reviva Pharmaceuticals stock with Buy rating - Investing.com Canada
Volatility Watch: Will Reviva Pharmaceuticals Holdings Inc Equity Warrant stock attract ESG investorsJuly 2025 Chart Watch & Verified Stock Trade Ideas - Bộ Nội Vụ
Reviva Pharmaceuticals Holdings Inc Stock Analysis and ForecastMarket Timing Techniques & Explosive Trading Portfolio - earlytimes.in
Relief Rally in Veeram Securities Limited Stock Can It HoldVolatility Adjusted Trading & Download Our Free Trading Blueprint - earlytimes.in
What analysts say about Reviva Pharmaceuticals Holdings Inc stockBollinger Bands Signals & Try Our Free Strategy Builder Now - earlytimes.in
Technical Charts Suggest Momentum Shift in Sapphire Foods India LimitedEarnings Forecast Updates & Learn to Trade with Real-Time Feedback - earlytimes.in
Largest borrow rate increases among liquid names - TipRanks
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum - The Manila Times
Dow Gains 100 Points; US Durable Goods Orders Decline In October - Sahm
Reviva Pharmaceuticals Holdings Inc. (RVPH) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Reviva Pharmaceuticals (RVPH) Stock Plunges After FDA Calls for Second Phase 3 Trial: News, Forecasts, and Analyst Takeaways on Dec. 24, 2025 - ts2.tech
Reviva Pharmaceuticals' (RVPH) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
Reviva Pharmaceuticals stock rating reiterated at Buy by H.C. Wainwright - Investing.com South Africa
D Boral Capital maintains Reviva Pharmaceuticals Holdings (RVPH) buy recommendation - MSN
Investors Purchase Large Volume of Call Options on Reviva Pharmaceuticals (NASDAQ:RVPH) - MarketBeat
FDA recommends second phase 3 trial for Reviva’s schizophrenia drug By Investing.com - Investing.com Nigeria
Reviva considers a second phase III in schizophrenia - BioWorld MedTech
Reviva Pharmaceuticals Holdings, Inc. (RVPH) stock: plunges 50% after FDA calls for second Phase 3 schizophrenia trial - parameter.io
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Why Did RVPH Stock Crash 50% Today? - Stocktwits
Reviva Pharmaceuticals stock plunges after FDA requests second Phase 3 trial By Investing.com - Investing.com Nigeria
Reviva Pharmaceuticals stock plunges after FDA requests second Phase 3 trial - Investing.com Nigeria
FDA Asks Reviva Pharmaceuticals To Conduct Additional Phase 3 Study For Its Schizophrenia Drug - Benzinga
Reviva Pharmaceuticals (NASDAQ:RVPH) Earns "Buy" Rating from D. Boral Capital - MarketBeat
Reviva plans second Phase 3 trial after FDA feedback - TipRanks
Finanzdaten der Reviva Pharmaceuticals Holdings Inc-Aktie (RVPH)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.44%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):